WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Ownership - Who owns Sarepta Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sarepta Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Claude NicaiseDirector2026-01-296,780$21.23
$143.94kSell
Claude NicaiseDirector2026-01-2910,500$13.71
$143.96kBuy
M. Kathleen BehrensDirector2026-01-276,494$22.17
$143.97kSell
M. Kathleen BehrensDirector2026-01-2710,500$13.71
$143.96kBuy
Ian Michael EstepanChief Operating Officer2025-12-1613,187$22.31
$294.20kSell
Ryan Hoyan WongChief Financial Officer2025-12-0180$20.96
$1.68kSell
Ryan Hoyan WongChief Financial Officer2025-12-0178$20.96
$1.63kSell
Cristin RothfussEVP General Counsel2025-11-28229$21.12
$4.84kSell
Louise RodinoklapacPresident RD and Tech Ops2025-11-174,582$18.42
$84.40kSell
Ryan Hoyan WongChief Financial Officer2025-07-31327$16.42
$5.37kSell

1 of 5

SRPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SRPT insiders and whales buy or sell their stock.

SRPT Shareholders

What type of owners hold Sarepta Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.60%13,199,845$244.20MInstitution
Vanguard Group Inc10.32%10,817,446$200.12MInstitution
Black Bear Offshore Master Fund LP9.46%9,914,211$183.41MInsider
Eastbourne Capital Management LLC5.40%5,659,211$104.70MInsider
State Street Corp5.06%5,304,907$98.14MInstitution
Richard Barry3.07%3,216,667$59.51MInsider
Rockall Emerging Markets Master Fund Ltd2.80%2,935,696$54.31MInsider
Erste Asset Management Gmbh2.56%2,685,945$49.69MInstitution
Renaissance Technologies LLC2.53%2,650,178$49.03MInstitution
George Weaver Haywood2.32%2,426,953$44.90MInsider

1 of 3

SRPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SRPT74.31%25.69%Net SellingNet Selling
NUVB58.03%41.97%Net BuyingNet Buying
AUPH49.82%12.67%Net BuyingNet Selling
ZLAB3.18%1.76%Net BuyingNet Selling
OCUL83.44%16.56%Net SellingNet Selling
View Top Biotech Stocks

Sarepta Therapeutics Stock Ownership FAQ

Who owns Sarepta Therapeutics?

Sarepta Therapeutics (NASDAQ: SRPT) is owned by 82.84% institutional shareholders, 28.65% Sarepta Therapeutics insiders, and 0.00% retail investors. Black Bear Offshore Master Fund LP is the largest individual Sarepta Therapeutics shareholder, owning 9.91M shares representing 9.46% of the company. Black Bear Offshore Master Fund LP's Sarepta Therapeutics shares are currently valued at $183.41M.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.